Post job

Lakewood-Amedex executives

Here are further demographic highlights of the leadership team:
  • The Lakewood-Amedex executive team is 10% female and 90% male.
  • 60% of the management team is White.
  • 13% of Lakewood-Amedex management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work at Lakewood-Amedex?
Share your experience

Rate Lakewood-Amedex's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Steve Parkinson

Board Member

Steve Parkinson's LinkedIn

Mr. Parkinson has more than 25 years of experience in the biopharmaceutical industry. As co-founder and CEO of TranXenoGen, Mr. Parkinson oversaw its IPO and admission to AIM in July of 2000, increasing its market value from $90M to $250M within one year. As President and CEO of CereMedix, a drug discovery and development company, he advanced their first product to clinical trials. Mr. Parkinson has raised both public and private capital, built management teams, managed M&A, in-licensed and out-licensed products/technology, and secured major industry contracts and collaborations for a number of companies including Advanced Cell Technology where he was CEO, Johnson & Johnson, PPL Therapeutics, Genzyme Transgenics and Fermetech Ltd.

Kelvin Cooper

Vice President, Research & Development, Kanneganti Murthy, Phd, Head, Preclinical Development

Peter F. Ceccacci

Chief Accounting Officer and Vice President

Peter B. Corr

Board Member

Richard Paul

Chief Medical and Scientific Officer

Thomas Pfisterer

Board Member

Charles F. Wright

Board Member

Doug Manion

Board Member

Dr. Kanneganti Murthy

Board Member

Leonard J. Deroma

Board Member

Do you work at Lakewood-Amedex?

Does the leadership team provide a clear direction for Lakewood-Amedex?

Lakewood-Amedex jobs

Lakewood-Amedex board members

Name & TitleBio
Steve Parkinson

Board Member

Steve Parkinson's LinkedIn

Mr. Parkinson has more than 25 years of experience in the biopharmaceutical industry. As co-founder and CEO of TranXenoGen, Mr. Parkinson oversaw its IPO and admission to AIM in July of 2000, increasing its market value from $90M to $250M within one year. As President and CEO of CereMedix, a drug discovery and development company, he advanced their first product to clinical trials. Mr. Parkinson has raised both public and private capital, built management teams, managed M&A, in-licensed and out-licensed products/technology, and secured major industry contracts and collaborations for a number of companies including Advanced Cell Technology where he was CEO, Johnson & Johnson, PPL Therapeutics, Genzyme Transgenics and Fermetech Ltd.

Kelvin Cooper

Vice President, Research & Development, Kanneganti Murthy, Phd, Head, Preclinical Development

Peter B. Corr

Board Member

Thomas Pfisterer

Board Member

Charles F. Wright

Board Member

Doug Manion

Board Member

Dr. Kanneganti Murthy

Board Member

Leonard J. Deroma

Board Member

Alfonso Ansi

Board Member

David Ng

Board Member

Zippia gives an in-depth look into the details of Lakewood-Amedex, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Lakewood-Amedex. The employee data is based on information from people who have self-reported their past or current employments at Lakewood-Amedex. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Lakewood-Amedex. The data presented on this page does not represent the view of Lakewood-Amedex and its employees or that of Zippia.

Lakewood-Amedex may also be known as or be related to Lakewood Amedex, Lakewood-Amedex and Lakewood-Amedex, Inc.